Data / Research funding / Colorado / Keystone Symposia
Keystone Symposia: 125 NIH awards ($1.6M), fiscal years 2021 to 2026
Keystone Symposia in Silverthorne, CO is funded under 125 NIH awards ($1.6M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- CER1EMNQ1663
- State
- Colorado
Awards
125 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Next Generation HIV Vaccines & Therapies | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $23,100 | February 1, 2021 | July 31, 2022 | JARVIS, THALE CROSS | reporter.nih.gov |
| Precision Genome Engineering | NIH | National Center for Advancing Translational Sciences | 2022 | $22,200 | February 1, 2022 | January 31, 2023 | JARVIS, THALE CROSS | reporter.nih.gov |
| HIV Vaccines, Immunoprophylaxis and Drugs | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $21,300 | April 1, 2023 | March 31, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Long COVID and Post Acute Sequalae of SARS CoV 2 (PASC): Pathogenesis and Treatment | NIH | National Heart, Lung, and Blood Institute | 2023 | $21,300 | August 15, 2023 | July 31, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Precision Genome Engineering | NIH | National Center for Advancing Translational Sciences | 2023 | $21,000 | February 1, 2023 | January 31, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Adipose Tissue: Energizing Good Fat | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 | $20,200 | January 1, 2023 | December 31, 2023 | JARVIS, THALE CROSS | reporter.nih.gov |
| Neuroimmunometabolism: Obesity at the Crossroads between Neuroimmunity and Immunometabolism | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $20,100 | August 1, 2022 | July 31, 2023 | JARVIS, THALE CROSS | reporter.nih.gov |
| Targeted Protein Degradation | NIH | National Center for Advancing Translational Sciences | 2023 | $20,100 | December 1, 2022 | November 30, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Neuronal Control of Appetite | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 | $20,000 | February 1, 2022 | December 31, 2022 | JARVIS, THALE CROSS | reporter.nih.gov |
| Organoids as Models of Development and Disease, and their Impact on Drug Discovery | NIH | National Center for Advancing Translational Sciences | 2023 | $19,800 | January 1, 2023 | December 31, 2023 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Spotlight on the Cancer Cell: Intrinsic Properties and Vulnerabilities for Therapeutics | NIH | National Cancer Institute | 2025 | $19,800 | August 6, 2025 | July 31, 2026 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Precision Engineering of the Genome, Epigenome, and Transcriptome | NIH | National Center for Advancing Translational Sciences | 2021 | $19,750 | March 4, 2021 | March 3, 2022 | JARVIS, THALE CROSS | reporter.nih.gov |
| Immunity and Aging | NIH | National Institute on Aging | 2023 | $19,230 | August 15, 2023 | July 31, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Metabolic and Molecular Mechanisms of NAFLD/NASH | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 | $19,200 | February 15, 2023 | January 31, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Obesity and Adipose Tissue | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $19,200 | January 1, 2025 | December 31, 2025 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Signals and Mechanisms Underlying the Benefits of Exercise | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 | $18,900 | July 1, 2023 | June 30, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Circulating Metabolic Intermediates as Fuels and Signals | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 | $18,900 | July 1, 2023 | June 30, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Precision Genome Engineering | NIH | National Center for Advancing Translational Sciences | 2024 | $18,900 | January 11, 2024 | December 31, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Neurodegenerative Diseases | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $18,900 | April 1, 2024 | March 31, 2025 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Neuroimmune Interactions: Nervous System and Immune Cell Heterogeneity in Health and Disease | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $18,900 | April 1, 2024 | March 31, 2025 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Molecular Basis of Healthy Aging | NIH | National Institute on Aging | 2023 | $18,600 | December 1, 2022 | November 30, 2023 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Human Microbiome: Diversity, Selection and Adaptation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $18,100 | February 1, 2025 | January 31, 2026 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Neurodegenerative Diseases: Genes, Mechanisms and Therapeutics | NIH | National Institute on Aging | 2021 | $18,000 | April 15, 2021 | March 31, 2022 | JARVIS, THALE CROSS | reporter.nih.gov |
| Inter Organ Crosstalk in Non-Alcoholic Steatohepatitis (NASH) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $18,000 | September 8, 2021 | August 31, 2022 | JARVIS, THALE CROSS | reporter.nih.gov |
| Tissue Fibrosis and Repair: Mechanisms, Human Disease and Therapies | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 | $18,000 | March 10, 2022 | February 28, 2023 | JARVIS, THALE CROSS | reporter.nih.gov |
| Non-Coding RNAs: Biology and Applications | NIH | National Human Genome Research Institute | 2021 | $17,800 | May 7, 2021 | April 30, 2022 | JARVIS, THALE CROSS | reporter.nih.gov |
| Immunometabolism at the Crossroads of Obesity and Cancer | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $17,800 | November 22, 2021 | October 31, 2022 | JARVIS, THALE CROSS | reporter.nih.gov |
| Drug Delivery to the Brain: Challenges and Progress | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $17,700 | September 1, 2022 | August 31, 2023 | JARVIS, THALE CROSS | reporter.nih.gov |
| Hematopoiesis | NIH | National Heart, Lung, and Blood Institute | 2024 | $17,700 | January 1, 2024 | December 31, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Stem Cells and Regeneration | NIH | National Heart, Lung, and Blood Institute | 2024 | $17,700 | February 1, 2024 | January 31, 2025 | SHEPPARD, TERRY L. | reporter.nih.gov |
| HIV and (Re)Emerging Viruses: Aligning Lessons Across Pandemics | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $17,700 | March 19, 2024 | February 28, 2025 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Bioenergetics in Health and Diseases | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 | $17,400 | January 1, 2023 | December 31, 2023 | JARVIS, THALE CROSS | reporter.nih.gov |
| Gut-Brain Axis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 | $17,200 | February 1, 2022 | December 31, 2022 | JARVIS, THALE CROSS | reporter.nih.gov |
| Modern Phenotypic Drug Discovery: From Chemical Biology to Therapeutics | NIH | National Center for Advancing Translational Sciences | 2022 | $17,200 | April 15, 2022 | April 14, 2023 | JARVIS, THALE CROSS | reporter.nih.gov |
| MASH Pathogenesis and Therapeutic Approaches | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $16,900 | January 8, 2025 | December 31, 2025 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Targeted Protein Degradation: From Small Molecules to Complex Organelles | NIH | National Center for Advancing Translational Sciences | 2021 | $16,800 | May 1, 2021 | April 30, 2022 | JARVIS, THALE CROSS | reporter.nih.gov |
| Adipose Tissue and Metabolic Health | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $16,800 | September 17, 2021 | August 31, 2022 | JARVIS, THALE CROSS | reporter.nih.gov |
| From First Breath: Lung Development, Infection, Repair and Aging | NIH | National Heart, Lung, and Blood Institute | 2023 | $16,500 | April 1, 2023 | March 31, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Delivery of Nucleic Acid Therapeutics | NIH | National Center for Advancing Translational Sciences | 2024 | $16,500 | January 16, 2024 | January 15, 2025 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Cardiometabolic Diseases: The Role of Ethnic Diversity in Precision Medicine | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 | $16,500 | February 3, 2024 | December 31, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Gene Regulation: Celebrating 40 Years of the Enhancer | NIH | National Human Genome Research Institute | 2021 | $16,200 | September 22, 2021 | August 31, 2022 | JARVIS, THALE CROSS | reporter.nih.gov |
| Heart Development and Disease: From Genes to Cures | NIH | National Heart, Lung, and Blood Institute | 2023 | $16,200 | February 1, 2023 | January 31, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Inborn Errors In Immunity | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $16,000 | August 1, 2022 | July 31, 2023 | JARVIS, THALE CROSS | reporter.nih.gov |
| Non-coding RNA Biology: New Roles & Diversity | NIH | National Human Genome Research Institute | 2024 | $15,700 | September 1, 2024 | August 31, 2025 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Drug Delivery to the Brain: Emerging Modalities | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $15,400 | January 3, 2025 | December 31, 2025 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Pulmonary Hypertension: State of the Art and Therapeutic Opportunities | NIH | National Heart, Lung, and Blood Institute | 2023 | $15,300 | April 1, 2023 | March 31, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Proximity Based Therapeutics | NIH | National Center for Advancing Translational Sciences | 2024 | $15,300 | January 1, 2024 | December 31, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Innate Immune Memory: From Evolutionary Roots to Human Disease | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $15,000 | December 1, 2021 | November 30, 2022 | JARVIS, THALE CROSS | reporter.nih.gov |
| Engineering Multi-Cellular Living Systems | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 | $15,000 | March 1, 2022 | February 28, 2023 | JARVIS, THALE CROSS | reporter.nih.gov |
| Organoids as Tools for Fundamental Discovery and Translation | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 | $15,000 | March 1, 2022 | February 28, 2023 | JARVIS, THALE CROSS | reporter.nih.gov |
| Autophagy and Neurodegeneration: Mechanisms to Therapies | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $15,000 | January 15, 2023 | December 31, 2023 | JARVIS, THALE CROSS | reporter.nih.gov |
| Genomic Instability and DNA Repair | NIH | National Cancer Institute | 2023 | $15,000 | March 28, 2023 | December 31, 2023 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Metastasis | NIH | National Cancer Institute | 2023 | $15,000 | April 6, 2023 | December 31, 2023 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Inflammation in the Lung: Friend or Foe in Viral Infections? | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $15,000 | April 1, 2023 | March 31, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| B Cell Biology in the Context of Infectious Diseases, Autoimmunity and B Cell Cancers | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $15,000 | March 10, 2023 | February 29, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Transposable Elements at the Crossroads of Evolution, Health and Disease | NIH | National Cancer Institute | 2023 | $15,000 | September 13, 2023 | August 31, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Mammalian Somatosensation: Mechanisms of Itch, Touch, Pain and Interoreception in Health and Disease | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $15,000 | January 1, 2024 | December 31, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Microbiota and Cancer Immunity | NIH | National Cancer Institute | 2024 | $15,000 | March 11, 2024 | February 28, 2025 | SHEPPARD, TERRY L. | reporter.nih.gov |
| T Cell Differentiation in Tissue Microenvironments | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $15,000 | July 9, 2024 | June 30, 2025 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Next Generation Antibody Therapeutics: From Discovery to Patient | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $14,400 | August 1, 2022 | July 31, 2023 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Obesity: Causes and Consequences | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 | $14,250 | February 1, 2024 | January 31, 2025 | SHEPPARD, TERRY L. | reporter.nih.gov |
| NASH and Fibrosis: From Molecular Phenotypes to Precision Therapeutics | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 | $14,250 | February 15, 2024 | January 31, 2025 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Myeloid Cells: Development, Diversity and Distinct Biological Roles | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $14,000 | November 1, 2022 | October 31, 2023 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Somatic Mosaicism in Human Development, Aging, and Diseases | NIH | National Human Genome Research Institute | 2025 | $13,300 | January 1, 2025 | December 31, 2025 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Type 2 Diabetes: Understanding its Early Drivers and the Road to Therapeutics | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 | $13,200 | April 5, 2023 | March 31, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Innate Immunity Across the Molecular, Cellular, Tissue and Therapeutic | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $13,000 | April 1, 2024 | March 31, 2025 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Trajectories to Heart Failure: Immunometabolic Mechanisms | NIH | National Heart, Lung, and Blood Institute | 2025 | $13,000 | January 1, 2025 | December 31, 2025 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Metabolic Decisions in Development and Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $12,500 | March 17, 2021 | December 31, 2021 | JARVIS, THALE CROSS | reporter.nih.gov |
| Myeloid Cell Diversity: From Fundamental Biology to Disease States | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $12,500 | August 10, 2023 | July 31, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Fatty Liver Disease and Multi-System Complications | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $12,000 | March 12, 2021 | December 31, 2021 | JARVIS, THALE CROSS | reporter.nih.gov |
| Neurocircuitry of Social Behavior | NIH | National Institute of Mental Health | 2022 | $12,000 | August 9, 2022 | August 8, 2023 | JARVIS, THALE CROSS | reporter.nih.gov |
| Epigenetic Mechanisms and the Treatment of Cancer | NIH | National Cancer Institute | 2024 | $12,000 | February 1, 2024 | January 31, 2025 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Novel Approaches Against Emerging Antimicrobial Resistance | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $11,000 | February 1, 2022 | January 31, 2023 | JARVIS, THALE CROSS | reporter.nih.gov |
| Innate Immunity: Complement and Beyond | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $11,000 | March 21, 2022 | February 28, 2023 | JARVIS, THALE CROSS | reporter.nih.gov |
| Lessons from the Pandemic: Responding to Emerging Zoonotic Viral Diseases | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $11,000 | April 4, 2022 | March 31, 2023 | JARVIS, THALE CROSS | reporter.nih.gov |
| Emerging Cellular Therapies at the Forefront of Cancer Immunotherapy | NIH | National Cancer Institute | 2023 | $11,000 | January 29, 2023 | June 30, 2023 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Regulation of Barrier Immunity | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $11,000 | December 1, 2023 | November 30, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Antibodies as Drugs: The Art in Antibody Engineering | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $11,000 | April 1, 2024 | March 31, 2025 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Obesity: From Cell to Patient | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $10,600 | January 1, 2021 | December 31, 2021 | JARVIS, THALE CROSS | reporter.nih.gov |
| Diabetes: Many Faces of the Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $10,000 | January 1, 2021 | December 31, 2021 | JARVIS, THALE CROSS | reporter.nih.gov |
| Myeloid Cells: From Birth to Immunity and Disease | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $10,000 | November 22, 2021 | October 31, 2022 | JARVIS, THALE CROSS | reporter.nih.gov |
| Cancer Immunotherapy: Decoding the Cancer Immunity Interactome | NIH | National Cancer Institute | 2022 | $10,000 | January 1, 2022 | December 31, 2022 | JARVIS, THALE CROSS | reporter.nih.gov |
| Micropeptides: Biogenesis and Function | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 | $10,000 | March 1, 2022 | February 28, 2023 | JARVIS, THALE CROSS | reporter.nih.gov |
| Infections in Pregnancy: PathogenicMechanisms, Experimental Advances and Clinical Strategies | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $10,000 | January 4, 2023 | December 31, 2023 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Heart Failure: All Cells Considered | NIH | National Heart, Lung, and Blood Institute | 2023 | $10,000 | May 1, 2023 | April 30, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Tumor Metabolism | NIH | National Cancer Institute | 2024 | $10,000 | January 24, 2024 | December 31, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Organoids: Engineering Innovative Approaches for Basic and Translational Insight | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $10,000 | April 18, 2025 | March 31, 2026 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Fibrosis: Inflammation, Drivers, and Therapeutic Resolution | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $9,500 | July 8, 2024 | June 30, 2025 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Innate Immune Memory: Mechanisms and Consequences | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $9,500 | July 11, 2024 | June 30, 2025 | SHEPPARD, TERRY L. | reporter.nih.gov |
| A Research Reboot of Tuberculosis on the Keystone Symposia 50th Anniversary | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $9,000 | November 2, 2021 | October 31, 2022 | JARVIS, THALE CROSS | reporter.nih.gov |
| Resolution of Inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $9,000 | April 4, 2022 | March 31, 2023 | JARVIS, THALE CROSS | reporter.nih.gov |
| Inhibitory Receptors in Immune Homeostasis, Disease and Therapy | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $9,000 | August 10, 2023 | July 31, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Innovative Vaccine Approaches | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $8,000 | June 23, 2021 | May 31, 2022 | JARVIS, THALE CROSS | reporter.nih.gov |
| Innate Immunity: From Innate Sensing to Adaptive Responses | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $8,000 | November 1, 2022 | October 31, 2023 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Cardiovascular Epigenetics and Gene Regulation | NIH | National Heart, Lung, and Blood Institute | 2024 | $8,000 | April 1, 2024 | March 31, 2025 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Vaccinology During and After COVID-19 | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $7,500 | July 20, 2023 | June 30, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| RNA Modifications in Health and Disease | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $7,500 | August 1, 2023 | July 31, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Malaria: Mechanisms of Immunity & Protection | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $7,500 | January 23, 2025 | December 31, 2025 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Tuberculosis: The Host-Pathogen Interface | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $7,000 | March 1, 2024 | February 28, 2025 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Tuberculosis: Heterogeneity from Experimental Models to Human Disease | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $6,500 | January 23, 2025 | December 31, 2025 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Mechanisms of Microbiota-Immune Interactions-Towards the Next Decade | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $6,000 | August 10, 2023 | July 31, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| B Cells and Tertiary Lymphoid Structures: Emerging Targets in Cancer Therapeutics | NIH | National Cancer Institute | 2023 | $6,000 | September 18, 2023 | August 31, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Fungal Pathogens: Emerging Threats and Future Challenges | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $6,000 | November 20, 2023 | October 31, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| RNA Mediated Regulation of Immunity: Mechanism, Disease and Therapeutics | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $6,000 | July 11, 2024 | June 30, 2025 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Progress in Vaccine Development for Infectious Diseases | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $5,500 | May 27, 2022 | April 30, 2023 | JARVIS, THALE CROSS | reporter.nih.gov |
| T and B Cell Collaboration in Germinal Centers and Beyond | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $5,500 | August 1, 2023 | July 31, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Cancer Stem Cells: Advances in Biology and Clinical Translation | NIH | National Cancer Institute | 2021 | $5,000 | March 1, 2021 | February 28, 2022 | JARVIS, THALE CROSS | reporter.nih.gov |
| Cancer Neoantigens, Vaccines and Viruses | NIH | National Cancer Institute | 2022 | $5,000 | March 1, 2022 | February 28, 2023 | JARVIS, THALE CROSS | reporter.nih.gov |
| The Human Microbiome: Ecology and Evolution | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $5,000 | January 20, 2022 | December 31, 2022 | JARVIS, THALE CROSS | reporter.nih.gov |
| Tumor Metabolism | NIH | National Cancer Institute | 2022 | $5,000 | December 3, 2021 | November 30, 2022 | JARVIS, THALE CROSS | reporter.nih.gov |
| Small Regulatory RNAs: From Bench to Bedside | NIH | National Cancer Institute | 2022 | $5,000 | April 27, 2022 | March 31, 2023 | JARVIS, THALE CROSS | reporter.nih.gov |
| Malaria: Confronting Challenges From Drug Discovery to Treatment | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $5,000 | April 4, 2022 | March 31, 2023 | JARVIS, THALE CROSS | reporter.nih.gov |
| Fibrosis Pathogenesis and Resolution: From Mechanisms to Therapies | NIH | National Heart, Lung, and Blood Institute | 2023 | $5,000 | March 15, 2023 | February 29, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Cancer Immunotherapy: Beyond Immune Checkpoint Blockade and Overcoming Resistance | NIH | National Cancer Institute | 2024 | $5,000 | January 1, 2024 | December 31, 2024 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Cancer: Aging in the Driver's Seat | NIH | National Cancer Institute | 2021 | $4,253 | August 1, 2021 | July 31, 2022 | JARVIS, THALE CROSS | reporter.nih.gov |
| Exosomes, Microvesicles and Other Extracellular Vesicles | NIH | National Cancer Institute | 2021 | $4,250 | August 1, 2021 | July 31, 2023 | JARVIS, THALE CROSS | reporter.nih.gov |
| Antibodies as Drugs: Innovative Formats, Design and Engineering | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $4,200 | November 18, 2024 | October 31, 2025 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Tumor Metabolism and the Microenvironment | NIH | National Cancer Institute | 2021 | $4,000 | February 1, 2021 | January 31, 2022 | JARVIS, THALE CROSS | reporter.nih.gov |
| Emerging Cell Therapies: Realizing the Vision of NextGen Cell Therapeutics | NIH | National Cancer Institute | 2021 | $4,000 | January 1, 2021 | December 31, 2021 | JARVIS, THALE CROSS | reporter.nih.gov |
| Humoral Immunity: From Regulation to Dysregulation | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $4,000 | March 21, 2022 | February 28, 2023 | JARVIS, THALE CROSS | reporter.nih.gov |
| Positive Strand RNA Viruses: Interdisciplinary Advances in Virology, Pathogenesis, Immunology, and Technology Development | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $4,000 | July 11, 2024 | June 30, 2025 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Host-Microbe Co-Evolution in Human Health: The Microbiome-Pathobiont Continuum | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $4,000 | November 18, 2024 | October 31, 2025 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Protein-RNA Interactions | NIH | National Cancer Institute | 2022 | $3,500 | September 1, 2022 | August 31, 2023 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Myeloid Cells: Roles in Different Tissue Microenvironments | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,400 | November 12, 2024 | November 11, 2025 | SHEPPARD, TERRY L. | reporter.nih.gov |
| Immunometabolism in Tissue Homeostasis and Diseases | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,200 | November 13, 2024 | October 31, 2025 | SHEPPARD, TERRY L. | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 14 | $154,500 | 0 | $0 |
| 2024 | 28 | $359,300 | 0 | $0 |
| 2023 | 35 | $499,130 | 0 | $0 |
| 2022 | 30 | $356,600 | 0 | $0 |
| 2021 | 18 | $221,053 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) | PA-25-080 | NIH | September 7, 2027 | Not listed | Notice number printed on 1 award here | |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 46 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 46 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 46 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 46 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 46 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 46 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 46 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 46 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 46 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 46 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 46 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 46 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 46 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 46 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 46 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 46 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 46 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 46 awards here |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | PA-24-185 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 46 awards here |
Topics of its NIH awards
- Biotechnology
- Infectious Diseases
- Cancer
- Genetics
- Immunization
- Vaccine Related
- Emerging Infectious Diseases
- Bioengineering
- Prevention
- Human Genome
- Immunotherapy
- Aging
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.